ETF concludes that bivalent original/Omicron BA.4-5 mRNA vaccines may be used for primary vaccination

6 December 2022 - EMA’s Emergency Task Force considers that adapted mRNA bivalent vaccines targeting the original strain and Omicron ...

Read more →

EU health regulator says COVID pandemic not over

20 September 2022 - An official at the European Union's drugs regulator said on Tuesday the COVID-19 pandemic was not ...

Read more →

Take whatever COVID booster you can get, says head of EU drugs watchdog

14 September 2022 - People in Europe should take whatever COVID-19 booster is available to them in the coming months, ...

Read more →

ECDC-EMA statement on booster vaccination with Omicron adapted bivalent COVID-19 vaccines

6 September 2022 - The European Centre for Disease Prevention and Control and the European Medicines Agency have issued a ...

Read more →

EMA’s Emergency Task Force advises on intradermal use of Imvanex/Jynneos against monkeypox

19 August 2022 - EMA’s Emergency Task Force (ETF) has reviewed data on the monkeypox vaccine Imvanex  used as an ...

Read more →

Big data use for public health: publication of Big Data Steering Group workplan 2022-25

28 July 2022 - The Big Data Steering Group set up by EMA and the Heads of Medicines Agencies has ...

Read more →

EMA response to the monkeypox public health emergency

27 July 2022 - The EMA has initiated a series of actions to respond to the ongoing monkeypox outbreak, which ...

Read more →

ECDC and EMA update recommendations on additional booster doses of mRNA COVID-19 vaccines

11 July 2022 - The European Centre for Disease Prevention and Control and the EMA are recommending that second booster ...

Read more →

Global regulators agree on key principles on adapting vaccines to tackle virus variants

1 July 2022 - On 30 June, regulators from around the world discussed emerging evidence to support adaptation of COVID-19 ...

Read more →

EMA adopts first list of critical medicines for COVID-19

8 June 2022 - On 7 June 2022, the EMA’s Medicines Shortages Steering Group adopted the list of critical medicines for ...

Read more →

International regulators and WHO: support health care professionals to enhance public confidence in COVID-19 vaccines

17 May 2022 - the EMA has endorsed a statement for health care professionals jointly developed by the International Coalition ...

Read more →

ECDC and EMA issue advice on fourth doses of mRNA COVID-19 vaccines

6 April 2022 - The European Centre for Disease Prevention and Control and EMA’s COVID-19 task force have concluded that ...

Read more →

EMA and ECDC recommendations on heterologous vaccination courses against COVID-19

7 December 2021 - ‘Mix-and-match’ approach can be used for both initial courses and boosters. ...

Read more →

EU drugs regulator to decide on Pfizer vaccine booster in early October

23 September 2021 - The EMA aims to decide in early October whether to endorse a third dose of the ...

Read more →

Update of EU recommendations for 2021–2022 seasonal flu vaccine composition

28 June 2021 - EMA has issued an update of the EU recommendations for the influenza virus strains that vaccine ...

Read more →